ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102 | +218.8% | 4,987 | +208.0% | 0.00% | – |
| Q2 2023 | $32 | -36.0% | 1,619 | -44.6% | 0.00% | – |
| Q1 2023 | $50 | -12.3% | 2,921 | 0.0% | 0.00% | – |
| Q4 2022 | $57 | -99.9% | 2,921 | +17.1% | 0.00% | – |
| Q3 2022 | $40,000 | +25.0% | 2,494 | +4.9% | 0.00% | – |
| Q2 2022 | $32,000 | -17.9% | 2,377 | +4.8% | 0.00% | – |
| Q1 2022 | $39,000 | -17.0% | 2,269 | +5.2% | 0.00% | – |
| Q4 2021 | $47,000 | -24.2% | 2,157 | +5.1% | 0.00% | – |
| Q3 2021 | $62,000 | -31.9% | 2,052 | 0.0% | 0.00% | – |
| Q2 2021 | $91,000 | +1.1% | 2,052 | 0.0% | 0.00% | – |
| Q1 2021 | $90,000 | -19.6% | 2,052 | 0.0% | 0.00% | – |
| Q4 2020 | $112,000 | +138.3% | 2,052 | 0.0% | 0.00% | – |
| Q3 2020 | $47,000 | +9.3% | 2,052 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +48.3% | 2,052 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -37.0% | 2,052 | 0.0% | 0.00% | – |
| Q4 2019 | $46,000 | -20.7% | 2,052 | -46.9% | 0.00% | – |
| Q2 2019 | $58,000 | -13.4% | 3,868 | 0.0% | 0.00% | – |
| Q1 2019 | $67,000 | +21.8% | 3,868 | 0.0% | 0.00% | – |
| Q4 2018 | $55,000 | -42.1% | 3,868 | 0.0% | 0.00% | – |
| Q3 2018 | $95,000 | +25.0% | 3,868 | 0.0% | 0.00% | – |
| Q2 2018 | $76,000 | – | 3,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |